A study investigating the association of dermatological and infusion reactions to infliximab and infliximab trough levels

BACKGROUND: Although infliximab is an effective therapy for inflammatory bowel disease (IBD), it is associated with dermatological events and infusion reactions. It is not known whether a relationship between these adverse events (AEs) and infliximab trough levels (ITLs) exists. OBJECTIVES: To repor...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Can J Gastroenterol Hepatol
Prif Awduron: Huang, Vivian Wai-Mei, Dhami, Neil, Fedorak, Darryl, Prosser, Connie, Shalapay, Carol, Kroeker, Karen Ivy, Halloran, Brendan Phillip, Dieleman, Levinus Albert, Fedorak, Richard Neil
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Pulsus Group Inc 2015
Pynciau:
Original Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4334065/
https://ncbi.nlm.nih.gov/pubmed/25706572
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg